[The combined rehabilitative treatment of the children with obesity and metabolic syndrome].
The present study included a total of 66 children at the age from 11 to 16 years with obesity and metabolic syndrome. The latter condition in the childhood and adolescence is characterized by the pronounced disturbances of basal metabolism, vasoactive systems, psychoemotional status, and regulatory hormonal functions that determine the choice of rehabilitative modalities. The combined treatment of such disturbances is considered to be an efficacious method for the rehabilitation of these patients. It is recommended that cortexin be prescribed to the children presenting with obesity and metabolic syndrome because this medication promotes correction of the hormonal and metabolic status and improves the brain cognitive function.
N P
NP
Stepanenko
E I
EI
Kondrat'eva
G A
GA
Sukhanova
N N
NN
Cherepanova
S V
SV
Alaĭtseva
T E
TE
Levitskaia
S S
SS
Shakhova
D001794:Blood Pressure / Q000502:physiology; D015992:Body Mass Index; D001835:Body Weight / Q000502:physiology; D002648:Child; D003131:Combined Modality Therapy; D004580:Electronarcosis / Q000379:methods*; D005260:Female; D006728:Hormones / Q000097:blood; D006801:Humans; D006875:Hydrotherapy / Q000379:methods*; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000175:diagnosis / Q000178:diet therapy / Q000523:psychology / Q000534:rehabilitation*; D009765:Obesity / Q000097:blood / Q000175:diagnosis / Q000178:diet therapy / Q000523:psychology / Q000534:rehabilitation*; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D055105:Waist Circumference
D006728:Hormones; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C056590:cortexin